Clinical Trial Update: A Phase 1 Study of IM-1021 in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating IM-1021 in adults with advanced solid tumors or hematologic malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• IM-1021

Snippet

Sponsor: Immunome, Inc. | Conditions: Solid Malignancies, Hematologic Malignancies | Phase 1 | Status: RECRUITING